Lipid peroxidation and antioxidant capacity of G6PD-deficient patients with A-(202G>A) mutation

Genetics and Molecular Research

Volumn 8, Issue 4, 2009, Pages 1345-1351

  Ondei, L S ^a   Silveira, L M ^a   Leite, A A ^a   Souza, D R S ^b   Pinhel, M A S ^b   Percario S ^c   Ricci Jr , O ^d   Bonini Domingos, C R ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d Hemocentro   (Brazil)

Author keywords

G6PD deficiency; Oxidative stress; TBARS; TEAC

Indexed keywords

GLUCOSE 6 PHOSPHATE DEHYDROGENASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TROLOX C;

ADOLESCENT; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; COLORIMETRY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; SEX DIFFERENCE; TROLOX EQUIVALENT ANTIOXIDANT CAPACITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BASE SEQUENCE; DNA PRIMERS; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; LIPID PEROXIDATION; MALE; MIDDLE AGED; MUTATION; YOUNG ADULT;

EID: 73449129014     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/vol8-4gmr662     Document Type: Article

References (27)

1. Beutler E (1984). Red Cell Metabolism. A Manual of Biochemical Methods. 3rd edn. Grune & Stratton Inc., London.
2. Beutler E (1994). G6PD deficiency. Blood 84: 3613-3636.
3. Beutler E (2008). Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood 111: 16-24.
4. Bilmen S, Aksu TA, Gumuslu S, Korgun DK, et al. (2001). Antioxidant capacity of G-6-PD-deficient erythrocytes. Clin. Chim. Acta 303: 83-86.
5. Brandt O, Rieger A, Geusau A and Stingl G (2008). Peas, beans, and the Pythagorean theorem - the relevance of glucose-6-phosphate dehydrogenase deficiency in dermatology. J. Dtsch. Dermatol. Ges. 6: 534-539.
6. Brewer GJ, Tarlov AR and Alving AS (1960). Methaemoglobin reduction test: a new, simple, in vitro test for identifying primaquine-sensitivity. Bull. World Health Organ. 22: 633-640.
7. Cappellini MD and Fiorelli G (2008). Glucose-6-phosphate dehydrogenase deficiency. Lancet 371: 64-74.
8. Castro S, Weber R, Dadalt V, Tavares V, et al. (2006). Prevalence of G6PD deficiency in newborns in the south of Brazil. J. Med. Screen. 13: 85-86.
9. Compri MB, Saad ST and Ramalho AS (2000). Genetic-epidemiological and molecular investigation of G-6-PD deficiency in a Brazilian community. Cad. Saúde Pública 16: 335-342.
10. Del Rio D, Stewart AJ and Pellegrini N (2005). A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr. Metab. Cardiovasc. Dis. 15: 316-328.
11. Frank JE (2005). Diagnosis and management of G6PD deficiency. Am. Fam. Physician 72: 1277-1282.
12. Gaetani GF, Rolfo M, Arena S, Mangerini R, et al. (1996). Active involvement of catalase during hemolytic crises of favism. Blood 88: 1084-1088.
13. Gerli GC, Beretta L, Bianchi M, Agostoni A, et al. (1982). Erythrocyte superoxide dismutase, catalase and glutathione peroxidase in glucose-6-phosphate dehydrogenase deficiency. Scand. J. Haematol. 29: 135-140.
14. Hamel AR, Cabral IR, Sales TS, Costa FF, et al. (2002). Molecular heterogeneity of G6PD deficiency in an Amazonian population and description of four new variants. Blood Cells Mol. Dis. 28: 399-406.
15. Martini G, Toniolo D, Vulliamy T, Luzzatto L, et al. (1986). Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. EMBO J. 5: 1849-1855.
16. Mason PJ, Bautista JM and Gilsanz F (2007). G6PD deficiency: the genotype-phenotype association. Blood Rev. 21: 267-283.
17. Mihara M and Uchiyama M (1978). Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86: 271-278.
18. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, et al. (1993). A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci. 84: 407-412.
19. Njålsson R and Norgren S (2005). Physiological and pathological aspects of GSH metabolism. Acta Paediatr. 94: 132-137.
20. Pandolfi PP, Sonati F, Rivi R, Mason P, et al. (1995). Targeted disruption of the housekeeping gene encoding glucose 6-phosphate dehydrogenase (G6PD): G6PD is dispensable for pentose synthesis but essential for defense against oxidative stress. EMBO J. 14: 5209-5215.
21. Pena SD, Macedo AM, Gontijo NF, Medeiros AM, et al. (1991). DNA bioprints: simple nonisotopic DNA fingerprints with biotinylated probes. Electrophoresis 12: 146-152.
22. Percário S, Vital AC and Jablonka F (1994). Dosagem do malondialdeído (MDA). Newslab. 2: 46-50.
23. Re R, Pellegrini N, Proteggente A, Pannala A, et al. (1999). Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 26: 1231-1237.
24. Saad ST, Salles TS, Carvalho MH and Costa FF (1997). Molecular characterization of glucose-6-phosphate dehydrogenase deficiency in Brazil. Hum. Hered. 47: 17-21.
25. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, et al. (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491.
26. Scott MD, Wagner TC and Chiu DT (1993). Decreased catalase activity is the underlying mechanism of oxidant susceptibility in glucose-6-phosphate dehydrogenase-deficient erythrocytes. Biochim. Biophys. Acta 1181: 163-168.
27. Zar JH (1999). Biostatistical Analysis. 4th edn. Prentice Hall, New Jersey.